In this context, our findings would not be contradictory to studies that have described an overexpression of GPC3 in the serum of patients with hepatocellular carcinoma [50,51], assuming that the soluble form of GPC3 was measured. This evidence concerns the gene GPC3 and hepatocellular carcinoma.